NGNE
Neurogene Inc.
Latest Form 4:Sale$22KbyCvijic Christine Mikail (President and CFO) · filed Jul 8, 2026
Neurogene Inc. (NGNE) has 13 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 8, 2026.
The most active filer is President and CFO Cvijic Christine Mikail with 8 filings. Insiders have net sold $1.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Rachel L. McMinn
- Employees:107
- HQ:New York City, NY, US
- IPO:2014-03-07
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$732.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| President and CFO | Sale | 600 | $22K | Jul 8 | SEC ↗ | |
| President and CFO | Sale | 4,200 | $152K | Jul 8 | SEC ↗ | |
| President and CFO | Sale | 739 | $25K | Jul 2 | SEC ↗ | |
| President and CFO | Sale | 4,061 | $141K | Jul 2 | SEC ↗ | |
| President and CFO | Sale | 9,600 | $300K | May 8 | SEC ↗ | |
McMinn RachelFirst filing | Chief Executive Officer | Sale | 3,352 | $74K | Mar 30 | SEC ↗ |
| President and CFO | Sale | 2,558 | $55K | Mar 30 | SEC ↗ | |
Jordan JulieFirst filing | Chief Medical Officer | Sale | 828 | $18K | Mar 30 | SEC ↗ |
Cobb StuartFirst filing | Chief Scientific Officer | Sale | 6,797 | $141K | Mar 17 | SEC ↗ |
| President and CFO | Sale | 4,045 | $84K | Mar 17 | SEC ↗ | |
Cvijic Christine MikailFirst filing | President and CFO | Sale | 4,800 | $121K | Mar 3 | SEC ↗ |
Related companies
Neurogene Inc. is in the Healthcare sector.